Cryoballoon Ablation System Market : Key Growth Factors and Industry Analysis 2017-2027

Cryoballoon ablation system is a minimally invasive treatment that is used cryo-thermal energy for pulmonary vein isolation in atrial fibrillation patients. Cryoballoon ablation systems are available in two different sizes (23 nm and 28 nm). The device consists of inner balloon and second non-compliant outer balloon. The cooling temperature for Cryoballoon ablation systems is approx. -80oC and it can be achieved by refrigerant nitrous oxide. The thermocouple is used to measure the temperature changes and it is at the proximal end of the balloon. Therefore, temperature changes are influenced by blood flow. Lesion formation with cryoballoon ablation system is complex, and freezing cycle involves both and thawing and freezing. It is the advantage of a cryoballoon ablation system that lesion formation is slower than other ablation techniques, resulting in recommended freezing cycles with 5 minutes duration. Because of this, cryoballoon ablation results in less thrombus formation and less endothelial disruption. Generally, cryoballoon ablation system uses extremely cold temperatures to destroy diseased tissue. The basic instrument includes cryotherapy diffuser which housed inside the balloon (self-sizing) and it has the ability to direct the cryoballoon to the targeted tissue. Cryoballoon conforms the shaping lumen without exerting any tension on the walls of the esophagus.

Drivers and Restraints

According to CDC, 2.7-6.1 Mn people in the USA have atrial fibrillation and its progress with age. Raising prevalence of atrial fibrillation fuels the growth of the cryoballoon ablation system market. Atrial fibrillation also affects physical condition, quality of life, social functioning and mental health of the individual. It also leads to dementia, stroke, cognitive heart attack and even death. Cryoballoon ablation system proven clinically for pulmonary vein isolation in atrial fibrillation and also reduces the risk of stroke, heart failure, dementia, and death. Cryoballoon ablation systems reduce the treatment duration and reduce the post-traumatic pains. Cryoballoon ablation system is more advantageous than traditionally available procedures because of it's cost-effective and minimally invasive nature respectively. Cryoballoon ablation system with a single application, it delivers continuous lesion around ostium and it is considered as a simplified approach for pulmonary vein isolation. All these factors act as a driver in the burgeoning of cryoballoon ablation system market.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-5964

Due to lack of flexibility and awareness in emerging markets limits the growth of the Cryoballoon Ablation System market.

Segmentation

Segmentation based on End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Market Overview

Global Cryoballoon Ablation System market has witnessed a robust growth due to increasing demand due to rising prevalence of atrial fibrillation. Cryoballoon Ablation System market has a presence of few regional players which have a huge market share in developing countries operating at regional or country level. There are huge opportunities for the untapped markets in emerging countries due to few approved players of the Cryoballoon Ablation System. The key players in the Cryoballoon Ablation System market are mainly focused on expansion by collaborations and partnerships with local vendors to increase the market reach of the products. The future of Cryoballoon Ablation System market anticipated with double CAGR during forecasting period.

Region-Wise Overview

Global Cryoballoon Ablation System market segmented into following regions North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and the Middle East and Africa. North America is dominant in the Global Cryoballoon Ablation System market mainly due to high adoption. In North America, particularly the USA is dominating due to the high penetration. Economic conditions in the APAC region are set to drive the Cryoballoon Ablation System market to new heights. European and APAC are fastest growing region due to raising awareness. Growth in the Middle East and African region is considerably less when compared to the other regions. However, North America would maintain its position in the Cryoballoon Ablation System market, though, we are anticipating emerging economies such India, China, Brazil, to have the highest growth rate in Cryoballoon Ablation System market.

Key Participants

The key participants in the Cryoballoon Ablation System market mainly include Synmed.CO.UK, Pentax Medical, Medtronic, and others. Companies are mainly focused on R&D to strengthen core competencies of the company’s product portfolio.